Literature DB >> 21325352

Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population.

Jan A J G van den Brand1, Gerben A J van Boekel, Hans L Willems, Lambertus A L M Kiemeney, Martin den Heijer, Jack F M Wetzels.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is defined as the presence of kidney damage, albuminuria or a reduction in glomerular filtration rate (GFR). A GFR <60 mL/min/1.73 m(2) alone is sufficient to diagnose CKD Stages III-V. Recently, the new chronic kidney disease epidemiology collaboration (CKD-EPI) equation was introduced. It has been suggested to result in higher estimated glomerular filtration rates (eGFRs) than the Modification of Diet in Renal Disease (MDRD(4)) formula. Here, we assess consequences of introducing the CKD-EPI equation in a West European Caucasian population.
METHODS: Data were obtained from 6097 Caucasian participants of the Nijmegen Biomedical Study (2823 males and 3274 females). Serum creatinine values were determined using the Jaffe method, calibrated against mass spectrometry and were used to calculate eGFR(MDRD4) and eGFR(CKD-EPI). Demographic data, health status and information on medication use for all participants was obtained with a postal questionnaire.
RESULTS: The introduction of the CKD-EPI equation changed the curve of eGFR by age, with higher values in the younger age groups and a steeper decline of eGFR with ageing. As a consequence, younger people were more often classified to a higher GFR stage and older people, especially males, to a lower GFR stage.
CONCLUSIONS: In comparison with the MDRD(4) formula, the CKD-EPI equation leads to higher estimates of GFR in young people and lower estimates in the elderly. On a population level, this may lead to higher estimates of kidney function. However, in routine clinical practice where the population is predominantly elderly, the opposite may be true. The introduction of eGFR(CKD-EPI) necessitates reconsidering the definition of CKD. We suggest introducing age-dependent threshold values and/or the use of urinary albumin excretion to improve risk stratification.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325352     DOI: 10.1093/ndt/gfr003

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  30 in total

1.  Lifetime Risk of CKD: What Does It Really Mean?

Authors:  Pierre Delanaye; Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-18       Impact factor: 8.237

2.  An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits.

Authors:  Pierre Delanaye; Richard J Glassock; Hans Pottel; Andrew D Rule
Journal:  Clin Biochem Rev       Date:  2016-02

3.  A Study of the Applicability of GFR Evaluation Equations for an Elderly Chinese Population.

Authors:  Q Huang; X Sun; Y Chen; M Zhang; L Tang; S Liu; R Wei; S Wang; J Zhou; X Cao; W Zhang; G Cai; X Chen
Journal:  J Nutr Health Aging       Date:  2015-06       Impact factor: 4.075

Review 4.  Structural and Functional Changes in Human Kidneys with Healthy Aging.

Authors:  Musab S Hommos; Richard J Glassock; Andrew D Rule
Journal:  J Am Soc Nephrol       Date:  2017-08-08       Impact factor: 10.121

5.  Renal function assessment in atrial fibrillation: Usefulness of chronic kidney disease epidemiology collaboration vs re-expressed 4 variable modification of diet in renal disease.

Authors:  Rami Riziq-Yousef Abumuaileq; Emad Abu-Assi; Andrea López-López; Sergio Raposeiras-Roubin; Moisés Rodríguez-Mañero; Luis Martínez-Sande; Francisco Javier García-Seara; Xesus Alberte Fernandez-López; Jose Ramón González-Juanatey
Journal:  World J Cardiol       Date:  2015-10-26

6.  Renal progression factors in young patients with tuberous sclerosis complex: a retrospective cohort study.

Authors:  Peter Janssens; Karen Van Hoeve; Liesbeth De Waele; Stéphanie De Rechter; Kathleen J Claes; Els Van de Perre; Karl Martin Wissing; Bert Bammens; Anna Jansen; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2018-07-09       Impact factor: 3.714

7.  Lifetime Risk of Stage 3-5 CKD in a Community-Based Sample in Iceland.

Authors:  Lesley A Inker; Hocine Tighiouart; Thor Aspelund; Vilmundur Gudnason; Tamara Harris; Olafur S Indridason; Runolfur Palsson; Shani Shastri; Andrew S Levey; Mark J Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-18       Impact factor: 8.237

8.  Comparison of chronic kidney disease prevalence examined by the chronic kidney disease epidemiology collaboration equation with that by the modification of diet in renal disease equation in Korean adult population.

Authors:  Sang-Yong Shin; Min-Jung Kwon; Hyosoon Park; Hee-Yeon Woo
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

9.  Prevalence of CKD and its relationship to eGFR-related genetic loci and clinical risk factors in the SardiNIA study cohort.

Authors:  Antonello Pani; Jennifer Bragg-Gresham; Marco Masala; Doloretta Piras; Alice Atzeni; Maria G Pilia; Liana Ferreli; Lenuta Balaci; Nicolò Curreli; Alessandro Delitala; Francesco Loi; Gonçalo R Abecasis; David Schlessinger; Francesco Cucca
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

10.  Association between ambient beta particle radioactivity and lower hemoglobin concentrations in a cohort of elderly men.

Authors:  Carolina L Z Vieira; Eric Garshick; Danilo Alvares; Joel Schwartz; Shaodan Huang; P Vokonas; Diane R Gold; Petros Koutrakis
Journal:  Environ Int       Date:  2020-04-15       Impact factor: 9.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.